DekaBank Deutsche Girozentrale Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$74.8M |
| 2 |
Sysco
SYY
|
+$54M |
| 3 |
ExxonMobil
XOM
|
+$42.4M |
| 4 |
Progressive
PGR
|
+$40.9M |
| 5 |
Mondelez International
MDLZ
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.68B |
| 2 |
Broadcom
AVGO
|
+$1.13B |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Canadian Natural Resources
CNQ
|
+$77.6M |
| 5 |
Gilead Sciences
GILD
|
+$60.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.08% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 10.83% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Discretionary | 9.68% |
Similar funds
DekaBank Deutsche Girozentrale's Q3 2024 Portfolio in Review
As of Q3 2024, DekaBank Deutsche Girozentrale held 1,489 positions worth $53.9B, down 2.9% from $55.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
DekaBank Deutsche Girozentrale withdrew a net $3.55B in Q3 2024, closing 60 positions and reducing 550 holdings. Its most notable exit was Labcorp, an estimated $36.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.
Against the trend, DekaBank Deutsche Girozentrale opened a new position in SolarEdge worth $1.5M.
- DekaBank Deutsche Girozentrale's largest Q3 2024 buy was SolarEdge: 66,000 shares worth $1.5M.
- DekaBank Deutsche Girozentrale added most to CVS Health in Q3 2024, an estimated $74.8M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $1.68B.
- DekaBank Deutsche Girozentrale fully exited Labcorp in Q3 2024, selling an estimated $36.3M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 26% of its $53.9B portfolio in Q3 2024.
- DekaBank Deutsche Girozentrale opened 41 new positions and closed 60 in Q3 2024.
- DekaBank Deutsche Girozentrale's portfolio value fell 2.9% quarter-over-quarter to $53.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2024, filed 24 Oct 2024.